Clinical trial Recruiting at 4 sites Interventional Ages 19 and up

Monitoring heart rhythms in patients with suspected arrhythmia

Official title: Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

Run by Wonju Severance Christian Hospital · NCT06250712 · Data updated 2026-11-12

This study is testing whether continuous ECG patches work better than handheld ECG devices for diagnosing arrhythmia symptoms in patients who haven't gotten clear results from standard tests.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment588 (estimated)
SponsorWonju Severance Christian Hospital
Academic / other
Locations4 sites (Gwangju, Dong-gu Jaebongro 42 and 3 other locations)
StatusRecruiting
StartedFebruary 22, 2024
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedOctober 5, 2026
Trial IDNCT06250712 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with arrhythmia symptoms who have not been diagnosed through a standard 12-lead ECG and can use a smartphone.

Probably not a fit

Patients with cardiac implantable electronic devices or those unable to use handheld ECG devices may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The HELP-A study is a single-center, randomized, controlled trial that aims to compare the effectiveness of continuous ECG patches versus intermittent handheld ECG devices in diagnosing arrhythmia symptoms. A total of 588 patients will be enrolled over two years and followed for one month to assess the diagnostic yield, detection rates, user convenience, and cost-effectiveness of both methods. Patients who exhibit arrhythmia symptoms but have inconclusive results from a standard 12-lead ECG will participate in this study, with the possibility of switching devices if no diagnosis is made within the initial month.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic accuracy for patients experiencing arrhythmia symptoms.

How similar studies have gone: Other studies have shown promise in using continuous ECG monitoring for arrhythmia detection, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 19 years or older.
* Palpitations or dizziness not explained by the presenting 12-lead ECG.
* A clinical indication for additional ambulatory ECG monitoring.
* Ownership of and ability to use a compatible smartphone.
* Ability to provide written informed consent and comply with study procedures

Exclusion Criteria:

* Physical disability or another condition that prevents appropriate use of the handheld ECG device.
* Presence of a cardiac implantable electronic device or ventricular assist device.
* Inability to read or understand the informed consent document.
* Any other condition that, in the investigator's judgment, makes participation in the study inappropriate.

Where it's running

  • Chonnam National University Hospital
    Gwangju, Dong-gu Jaebongro 42, South Korea
    Recruiting
  • Wonju Severance Christian Hospital
    Wŏnju, Gangwon-do, South Korea
    Recruiting
  • Hallym University Dongtan Sacred Heart Hospital
    Gyeonggi-do, Hwaseong-si Keunjaebong-gil 7, South Korea
    Recruiting
  • Korea University Anam Hospital
    Seoul, Seongbuk-gu, 73 Goryeodae-ro, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.